Skip to main content
. 2009 Oct 6;12(Suppl 1):S4. doi: 10.1186/1758-2652-12-S1-S4

Figure 5.

Figure 5

Virological suppression sratified by baseline CD4+ counts (>/< 50 cell/mm3). Source: Madero, S. et al. A prospective, randomized, open label trial of efavirenz versus lopinavir/ritonavir based HAART among antiretroviral therapy naïve, HIV infected individuals presenting for care with CD4 cell counts. (TUAB0104)